TMDX Similar Chart Price Prediction
The price of TMDX is predicted to go up -1.91%, based on the high correlation periods with SBCF. The similarity of these two price pattern on the periods is 96.84%.
TMDX
SBCF
Down: -1.91%Similarity: 96.84%
TMDX Revenue Forecast
TMDX EPS Forecast
TMDX FAQs
What is bull’s view on TMDX?
What is bear's view on TMDX?
What is TMDX revenue forecast for next quarter？
What is TMDX eps forecast for next quarter？
TMDX Analyst's Forecast
Allen Gong
JP Morgan
Buy → Hold
2024-12-17
Price Target
$116 → $75
Upside
+14.15%
JPMorgan analyst Allen Gong downgraded TransMedics to Neutral from Overweight with a price target of $75, down from $116. The company's near-term outlook "remains less certain" as questions remain on the softness seen in Q3 and Q4, and the setup is further complicated by a back-end-loaded 2025 guidance "that looks more achievable than beatable," the analyst tells investors in a research note. The firm thinks SMid-cap growth stories "need to demonstrate meaningful near-term upside to truly outperform," and thus is downgrading TransMedics heading into 2025.
Joe Vruwink
Baird
Buy
2024-12-11
Price Target
$150 → $120
Upside
+78.15%
Mike Matson
Needham
Strong Buy → Hold
2024-11-22
Price Target
$109
Upside
+43.35%
